October 24, 2020         
Equity and Inclusion Take Center Stage at 50th Anniversary LABC Architectural Awards   •   Zayed Award for Human Fraternity Judging Committee meets with Pope   •   Dorsey Recognized as a 2020 Best Adoption-Friendly Workplace by Dave Thomas Foundation for Adoption   •   Acushnet Holdings Corp. to Announce Third-Quarter Financial Results on November 6, 2020   •   NALCAB Hosts Virtual Latino Policy Summit to Explore Priority Issues, Solutions for Nation’s Economic Recovery   •   New AARP Dashboard Reveals Ohio's Efforts to Protect Nursing Home Residents During Coronavirus Pandemic Still Fall Short   •   COVID-19 in the Americas Conference sets out to “Re-think Everything”   •   Corporate Social Responsibility Related News Releases and Story Ideas for Reporters, Bloggers and Media Outlets   •   Research Finds Girls' Schools Graduate Global Changemakers   •   Cool Creek Family Health Launches a New Type of Medical Care in Carmel   •   Government of Canada extends deadline to apply for the Disability Tax Credit to receive the COVID-19 one-time payment for person   •   Psychedelic Feminism Goes Global   •   DMS Identifies Ecommerce Growth Trends for Advertisers Ahead Of Holiday Season   •   Government of Canada appoints Federal Special Representative to facilitate discussions between commercial lobster industry and F   •   Student Laptop Drive Raises $67,000 for Laptops 4 Learning   •   Limited edition 2021 Ford Bronco up for bid, supporting St. Jude Detroit Gala, Michigan native Danny Thomas' dream to end childh   •   Mastercard Recognizes Women’s Small Business Month Expanding Partnership with Impact Investment Platform CNote   •   President & CEO Cheryl McKissack Daniel Of McKissack & McKissack Featured In 'Our America: Living While Black' 60-Minute   •   Fashwire Awarded Coveted First-Place Award at Startup Grind’s Inaugural Virtual Global Pitch Battle Competition   •   Viamonte At Walnut Creek Reopens Preview Center Ahead of Community Completion
Bookmark and Share

CDI Labs HuProt™ Protein arrays instrumental in recent study of Multisystem Inflammatory Syndrome in Children (MIS-C)

CDI Labs HuProt™ Protein arrays instrumental in recent study of Multisystem Inflammatory Syndrome in Children (MIS-C)

Proteomics company CDI Laboratories products used in important study of MIS-C and its relationship to SARS-CoV-2 (COVID-19) infection.

PR Newswire

MAYAGUEZ, Puerto Rico and BALTIMORE, Sept. 23, 2020 /PRNewswire/ -- CDI Laboratories, Inc. HuProt protein microarray provided important data on a recent high impact paper comparing the immune profiles of MIS-C, healthy children and individuals with COVID-19.

(see https://www.newswise.com/coronavirus/mount-sinai-researchers-study-sars-cov2-caused-mis-c )

In recent months some children that have been infected with SARS-CoV-2 (COVID-19) have developed an inflammatory problem that was initially recognized as very similar in presentation to Kawasaki disease (KD), an acute systemic vasculitis.

A recent paper has mapped the cellular and serological immune dysfunction underlying this novel pediatric inflammatory syndrome associated with SARS-CoV-2, and helped define how this unique disease differs from Kawasaki disease..

Mapping Systemic Inflammation and Antibody Responses in Multisystem

Inflammatory Syndrome in Children (MIS-C)

Conor Gruber, et al.

PII: S0092-8674(20)31231-9

DOI: https://doi.org/10.1016/j.cell.2020.09.034

Reference: CELL 11634

In the above paper auto-antigen reactivity of MIS-C plasma was assayed with CDI Laboratories HuProt protein arrays which contain 81% of the human proteome. This work revealed both known autoimmune-associated autoantibodies (anti-La) and novel candidates that recognize endothelial, gastrointestinal and immune-cell antigens unique to organs affected by MIS-C.

"CDI is very proud that our HuProt array was so useful in looking into this perplexing side effect of COVID-19 infection in children," said Scott Paschke, CDI VP. "Furthermore, PhIP-Seq technology was also used to look at linear epitopes of auto-antibodies, which is another technology that CDI has recently added."

About CDI – CDI is a privately-owned biotechnology corporation, that focuses on contract research services to enable R&D of future therapeutic and diagnostic tools to proceed more rapidly and cost-effectively. The Company exports products and offers services worldwide and is rapidly expanding its client base and its academic and industrial collaborations.

For more information, visit https://cdi.bio/ or  https://cdi.bio/antygen



Media Contact:

Scott Paschke, VP

CDI Laboratories Inc

518-534-2881 (direct)


Cision View original content:http://www.prnewswire.com/news-releases/cdi-labs-huprot-protein-arrays-instrumental-in-recent-study-of-multisystem-inflammatory-syndrome-in-children-mis-c-301135802.html

SOURCE CDI Laboratories

Back to top
| Back to home page

White House Live Stream
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News